CJC-1295 DAC (5 mg Vial) & Ipamorelin (5 mg Vial)

01 · At a glance

Quickstart Highlights

CJC-1295 DAC (5 mg Vial) & Ipamorelin (5 mg Vial) dosage protocol combines two research peptides frequently studied together for their synergistic effects on growth hormone (GH) release. CJC-1295 DAC ~1–2 mg per week (once or twice weekly) Ipamorelin ~300–500 mcg per day (1–2 daily injections for standard use) Common cycle length is 4–8 weeks, based on research requirements Reconstitute each vial with bacteriostatic water (up to 3 mL per vial) Keep reconstituted vials refrigerated (2–8°C) and use within 14–28 days

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

CJC-1295 DAC (5 mg Vial): Standard / Gradual Approach

Reference dose shown on this page: See guide.

Advanced / Aggressive Approach

Reconstitution Steps

1. Confirm the vial amount, unit, and diluent amount before entering values in the calculator.
2. Add diluent slowly down the inner wall of the vial when reconstitution is appropriate for the compound.
3. Swirl or roll gently until dissolved; avoid shaking unless the product instructions specifically say otherwise.
4. Label the vial with the date and concentration, then store according to the protocol and product instructions.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Enhanced GH release, potential synergy in injury repair or performance CJC-1295 DAC: 1–3 mg weekly (1–3 injections) Ipamorelin: ~300–700 mcg daily, split if necessary Cycle Length: 4–8 weeks; re-assess as needed
• Reconstitution: Up to 3 mL total to maintain practical syringe units

Dosing Protocol

• Reference dose shown on this page: See guide.
• Weeks 1–4 1–2 mg/week 0.5–1 mg ~0.2–0.4 mL (20–40 units) 1–2× per week For example, if you plan on using 2 mg per week in 2 injections: each injection is ~1 mg (0.4 mL or ~40 units). Lower weekly totals (1 mg/week) might require just one injection of 0.4 mL. Draw 2.0 mL of bacteriostatic water into a sterile syringe. Inject slowly along the vial wall to minimize foam. Gently swirl the vial—avoid vigorous shaking. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
• If values change, rerun the calculator and update the protocol so future logs match the active plan.

Storage Instructions

• Proper handling preserves peptide quality.
• Lyophilized: Store at 2–8°C until ready to mix
• Reconstituted: Refrigerate at 2–8°C; use within 14–28 days Protect from light; keep vials upright if possible Avoid repeated freeze-thaw cycles

04 · Good to know

Important Notes

• Tips for safe, consistent research usage.
• Use new, sterile insulin syringes for each injection; rotate injection sites.
• Maintain consistent protocol; peptides often show best outcomes with regular dosing.
• Monitor for adverse reactions; consult a professional if concerns arise.
• Never mix CJC-1295 DAC and Ipamorelin in the same syringe; reconstitute each in its own vial.

05 · How it works

How This Works

CJC-1295 DAC (5 mg Vial) & Ipamorelin (5 mg Vial) dosage protocol combines two research peptides frequently studied together for their synergistic effects on growth hormone (GH) release.

CJC-1295 DAC ~1–2 mg per week (once or twice weekly) Ipamorelin ~300–500 mcg per day (1–2 daily injections for standard use) Common cycle length is 4–8 weeks, based on research requirements Reconstitute each vial with bacteriostatic water (up to 3 mL per vial) Keep reconstituted vials refrigerated (2–8°C) and use within 14–28 days

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• Research explores various benefits, with some caution for side effects.
• Possible support for muscle repair, injury recovery, and collagen synthesis Increased GH and IGF-1 can lead to improved tissue repair in certain models Potential mild side effects: injection-site irritation, water retention, headaches Long-term safety and efficacy continue to be investigated

08 · Technique

Injection Technique

09 · Evidence

References